Understanding the costs of drug-related actions is an important aspect of drug policy. Some of the funds allocated by governments to expenditure on tasks related to drugs are identified as such in the budget (‘labelled’). Often, however, most drug-related expenditure is not identified (‘unlabelled’) and must be estimated using modelling approaches.
The national action plan has a planned annual drug-related budget. Additionally, labelled and unlabelled drug-related expenditures have been estimated annually since 2009, based on a well-defined methodology. In 2014, the efficiency of public spending and its compliance with the strategic priorities of the national strategy and the action plan were assessed. In 2016, a study was initiated to set the evaluation methodology for the provision of drug-related interventions and their costs in areas such as law enforcement, healthcare and social welfare. The aim is to link high-quality standards of public service provision to funding practices.
Total drug-related public expenditure in 2016 represented 0.24 % of gross domestic product. The Croatian government spent approximately EUR 111.8 million, of which 79.0 % financed public order and safety activities and 18.6 % financed healthcare, while approximately 2.4 % financed education, social protection and general public services.